Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis

Smoll NR, Hamilton B (2014) Incidence and relative survival of anaplastic astrocytomas. Neuro Oncol 16:1400–1407

Article  PubMed  PubMed Central  Google Scholar 

Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y et al (2013) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol 15 Suppl 2:ii1–56

Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A et al (2013) High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Int J Radiat Oncol Biol Phys 87:1100–1106

Article  PubMed  Google Scholar 

Pedicini P, Fiorentino A, Simeon V, Tini P, Chiumento C, Pirtoli L et al (2014) Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes. Strahlenther Onkol 190:925–932

Article  PubMed  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

Article  CAS  PubMed  Google Scholar 

Do V, Gebski V, Barton MB (2000) The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 57:131–136

Article  CAS  PubMed  Google Scholar 

Irwin C, Hunn M, Purdie G, Hamilton D (2007) Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 85:339–343

Article  PubMed  Google Scholar 

Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306–2316

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C (2020) Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: a real-world assessment using the national cancer database. Sci Rep 10:4926

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 98:603–609

Article  PubMed  Google Scholar 

Ostrom QT, Krebs HL, Patil N, Cioffi G, Barnholtz-Sloan JS (2021) Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US. J Neurooncol 152:603–615

Article  PubMed  Google Scholar 

Bilimoria KY, Stewart AK, Winchester DP, Ko CY (2008) The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 15:683–690

Article  PubMed  PubMed Central  Google Scholar 

Yadav K, Lewis RJ (2021) Immortal time bias in observational studies. JAMA 325:686–687

Article  PubMed  Google Scholar 

Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515–526

Article  Google Scholar 

Paul HCE, Marx BD (1996) Flexible smoothing with $B$-splines and penalties. Stat Sci 11:89–102

Google Scholar 

Team RC: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/, 2013

Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076–2084

Article  PubMed  Google Scholar 

Brat DJ (2012) Glioblastoma: biology, genetics, and behavior. Am Soc Clin Oncol Educ Book 32:102–107

Article  Google Scholar 

Shin JY, Diaz AZ (2016) Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy. J Neurooncol 129:557–565

Article  CAS  PubMed  Google Scholar 

Shin JY, Yoon JK, Diaz AZ (2017) Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients. J Neurooncol 132:89–98

Article  PubMed  Google Scholar 

Ryckman JM, Surkar SM, Haque W, Butler EB, Teh BS, Verma V (2019) Sequencing of chemotherapy and radiotherapy for newly diagnosed anaplastic oligodendroglioma and oligoastrocytoma. Am J Clin Oncol 42:258–264

Article  PubMed  Google Scholar 

Jacobs CD, Carpenter DJ, Hong JC, Havrilesky LJ, Sosa JA, Chino JP (2019) Radiation records in the National Cancer Database: variations in coding and/or practice can significantly alter survival results. JCO Clin Cancer Inform 3:1–9

PubMed  Google Scholar 

Yang DX, Khera R, Miccio JA, Jairam V, Chang E, James BY et al (2021) Prevalence of missing data in the National Cancer Database and association with overall survival. JAMA Netw Open 4:e211793–e211793

Article  PubMed  PubMed Central  Google Scholar 

Haque W, Thong E, Andrabi S, Verma V, Butler EB, Teh BS (2021) Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas. J Clin Neurosci 85:115–121

Article  CAS  PubMed  Google Scholar 

Blumenthal DT, Won M, Mehta MP, Curran WJ, Souhami L, Michalski JM et al (2009) Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol 27:733–739

Article  PubMed  Google Scholar 

Lawrence YR, Blumenthal DT, Matceyevsky D, Kanner AA, Bokstein F, Corn BW (2011) Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line? J Neurooncol 105:1–7

Article  CAS  PubMed  Google Scholar 

Loureiro LV, Victor Eda S, Callegaro-Filho D, Koch Lde O, Pontes Lde B, Weltman E et al (2016) Minimizing the uncertainties regarding the effects of delaying radiotherapy for Glioblastoma: a systematic review and meta-analysis. Radiother Oncol 118:1–8

Article  PubMed  Google Scholar 

Wang TJ, Jani A, Estrada JP, Ung TH, Chow DS, Soun JE et al (2016) Timing of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients. Neurosurgery 78:676–682

Article  PubMed  Google Scholar 

Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337

Article  CAS  PubMed  Google Scholar 

Lassman AB, Hoang-Xuan K, Polley M-YC, Brandes AA, Cairncross JG, Kros JM et al (2022) Joint final report of EORTC 26951 and RTOG 9402: phase III trials with procarbazine, lomustine, and vincristine chemotherapy for anaplastic oligodendroglial tumors. J Clin Oncol 40:2539–2545

Article  CAS  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncology 23:1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Bent MJ, Tesileanu CMS, Wick W, Sanson M, Brandes AA, Clement PM et al (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053–22054): second interim analysis of a randomised, open-label, phase 3 study. Lancet Oncol 22:813–823

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif